GRAIL vs Doximity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Doximity leads in AI visibility (86 vs 54)
GRAIL logo

GRAIL

GrowthHealthcare

Liquid Biopsy Cancer Detection

GRAIL develops multi-cancer early detection Galleri test using cell-free DNA methylation to detect signals from 50+ cancer types in a single blood draw; spun off from Illumina in 2024; NHS-Galleri trial enrolling 140,000 participants in the UK.

AI VisibilityBeta
Overall Score
C54
Category Rank
#185 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
60
Perplexity
53
Gemini
57

About

GRAIL is a healthcare company founded in 2016 as an Illumina spinout focused on developing multi-cancer early detection tests using liquid biopsy technology. The company's flagship product Galleri is a blood test that analyzes cell-free DNA methylation patterns to detect cancer signals from over 50 cancer types, many of which lack standard screening tests, enabling detection at early stages when treatment is most effective. GRAIL raised over $3.5B from investors including Amazon and Bristol Myers Squibb and was reacquired by Illumina in 2021 before being spun off again in 2024 as an independent public company following regulatory complications. Galleri has been launched commercially and is being evaluated in large clinical studies including the NHS-Galleri trial in the UK enrolling 140,000 participants. The company represents a transformative approach to oncology that could shift cancer care from reactive treatment toward proactive screening. GRAIL's technology addresses a massive unmet need given that the majority of cancers are diagnosed at late stages when outcomes are poor.

Full profile
Doximity logo

Doximity

GrowthHealthTech

Physician Professional Network

Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.

AI VisibilityBeta
Overall Score
A86
Category Rank
#6 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
84
Gemini
88

About

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.

Full profile

AI Visibility Head-to-Head

54
Overall Score
86
#185
Category Rank
#6
82
AI Consensus
85
stable
Trend
stable
60
ChatGPT
85
53
Perplexity
84
57
Gemini
88
59
Claude
81
55
Grok
85

Key Details

Category
Liquid Biopsy Cancer Detection
Physician Professional Network
Tier
Growth
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only GRAIL
Liquid Biopsy Cancer Detection
Only Doximity
Physician Professional Network

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.